293 related articles for article (PubMed ID: 15757153)
1. [Successful esophageal pH monitoring with Bravo capsule in patients with gastroesophageal reflux disease].
Valdovinos Díaz MA; Remes Troche JM; Ruiz Aguilar JC; Schmulson MJ; Valdovinos-Andraca F
Rev Gastroenterol Mex; 2004; 69(2):62-8. PubMed ID: 15757153
[TBL] [Abstract][Full Text] [Related]
2. Performance, tolerability, and symptoms related to prolonged pH monitoring using the Bravo system in Mexico.
Remes-Troche JM; Ibarra-Palomino J; Carmona-Sánchez RI; Valdovinos MA
Am J Gastroenterol; 2005 Nov; 100(11):2382-6. PubMed ID: 16279888
[TBL] [Abstract][Full Text] [Related]
3. Ambulatory esophageal pH monitoring using a wireless system.
Pandolfino JE; Richter JE; Ours T; Guardino JM; Chapman J; Kahrilas PJ
Am J Gastroenterol; 2003 Apr; 98(4):740-9. PubMed ID: 12738450
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy, diagnostic utility and tolerance of intraesophageal pH ambulatory determination with wireless pH-testing monitoring system].
Carmona-Sánchez R; Solana-Sentíes S
Rev Gastroenterol Mex; 2004; 69(2):69-75. PubMed ID: 15757154
[TBL] [Abstract][Full Text] [Related]
5. Oesophageal pH monitoring using the Bravo catheter-free radio capsule.
Gillies RS; Stratford JM; Booth MI; Dehn TC
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):57-63. PubMed ID: 17206078
[TBL] [Abstract][Full Text] [Related]
6. Bravo capsule placement in the gastric cardia: a novel method for analysis of proximal stomach acid environment.
Pandolfino JE; Schreiner MA; Lee TJ; Zhang Q; Kahrilas PJ
Am J Gastroenterol; 2005 Aug; 100(8):1721-7. PubMed ID: 16086707
[TBL] [Abstract][Full Text] [Related]
7. Wireless pH recording immediately above the squamocolumnar junction improves the diagnostic performance of esophageal pH studies.
Wenner J; Hall M; Höglund P; Johansson J; Johnsson F; Oberg S
Am J Gastroenterol; 2008 Dec; 103(12):2977-85. PubMed ID: 18786112
[TBL] [Abstract][Full Text] [Related]
8. [Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)].
Mönkemüller K; Neumann H; Fry LC; Kolfenbach S; Malfertheiner P
Z Gastroenterol; 2009 Apr; 47(4):351-6. PubMed ID: 19358061
[TBL] [Abstract][Full Text] [Related]
9. Accuracy and tolerability of the Bravo catheter-free pH capsule in patients between the ages of 4 and 18 years.
Croffie JM; Fitzgerald JF; Molleston JP; Gupta SK; Corkins MR; Pfefferkorn MD; Lim JR; Steiner SJ; Dadzie SK
J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):559-63. PubMed ID: 18030233
[TBL] [Abstract][Full Text] [Related]
10. Safety and tolerability of transoral Bravo capsule placement after transnasal manometry using a validated conversion factor.
Lacy BE; O'Shana T; Hynes M; Kelley ML; Weiss JE; Paquette L; Rothstein RI
Am J Gastroenterol; 2007 Jan; 102(1):24-32. PubMed ID: 17100980
[TBL] [Abstract][Full Text] [Related]
11. Impact of measurement of esophageal acid exposure close to the gastroesophageal junction on diagnostic accuracy and event-symptom correlation: a prospective study using wireless dual pH monitoring.
Bansal A; Wani S; Rastogi A; Rastogi K; Goyal A; Hall S; Singh V; Higbee A; Sharma P
Am J Gastroenterol; 2009 Dec; 104(12):2918-25. PubMed ID: 19755975
[TBL] [Abstract][Full Text] [Related]
12. Ambulatory esophageal pH monitoring by using a wireless system: a pilot study in Taiwan.
Tu CH; Lee YC; Wang HP; Wu MS; Chiu HM; Lin JT
Hepatogastroenterology; 2004; 51(60):1586-9. PubMed ID: 15532783
[TBL] [Abstract][Full Text] [Related]
13. Tolerability and clinical utility of the Bravo pH capsule in children.
Lacy BE; Edwards S; Paquette L; Weiss J; Kelley ML; Ornvold K
J Clin Gastroenterol; 2009 Jul; 43(6):514-9. PubMed ID: 19349903
[TBL] [Abstract][Full Text] [Related]
14. [Perception of symptoms with minimal reductions of esophageal pH in patients with erosive and non-erosive GERD].
Remes-Troche JM; Gómez-Escudero O; Ruíz JC; Schmulson MJ; Valdovinos Díaz MA
Rev Gastroenterol Mex; 2004; 69(1):30-6. PubMed ID: 15193061
[TBL] [Abstract][Full Text] [Related]
15. Wireless pH monitoring in patients with non-cardiac chest pain.
Prakash C; Clouse RE
Am J Gastroenterol; 2006 Mar; 101(3):446-52. PubMed ID: 16542279
[TBL] [Abstract][Full Text] [Related]
16. Nonendoscopic transnasal placement of a wireless capsule for esophageal pH monitoring: feasibility, safety, and efficacy of a manometry-guided procedure.
Marchese M; Spada C; Iacopini F; Familiari P; Shah SG; Tringali A; Costamagna G
Endoscopy; 2006 Aug; 38(8):813-8. PubMed ID: 17001571
[TBL] [Abstract][Full Text] [Related]
17. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
[TBL] [Abstract][Full Text] [Related]
18. Dual site ambulatory pH monitoring: a probe across the lower esophageal sphincter does not induce gastroesophageal reflux.
Decktor DL; Krawet SH; Rodriguez SL; Robinson M; Castell DO
Am J Gastroenterol; 1996 Jun; 91(6):1162-6. PubMed ID: 8651164
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic usefulness of the Carlsson-Dent questionnaire in gastroesophageal reflux disease (GERD)].
Gómez-Escudero O; Remes-Troche JM; Ruíz JC; Peláez-Luna M; Schmulson MJ; Valdovinos Díaz MA
Rev Gastroenterol Mex; 2004; 69(1):16-23. PubMed ID: 15193059
[TBL] [Abstract][Full Text] [Related]
20. Comparison of esophageal acid exposure at 1 cm and 6 cm above the squamocolumnar junction using the Bravo pH monitoring system.
Pandolfino JE; Lee TJ; Schreiner MA; Zhang Q; Roth MP; Kahrilas PJ
Dis Esophagus; 2006; 19(3):177-82. PubMed ID: 16722995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]